Bromatech Biomed Ltd 11393061 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is Other professional, scientific and technical activities not elsewhere classified Digita Accounts Production Advanced 6.30.9574.0 true 11393061 2023-01-01 2023-12-31 11393061 2023-12-31 11393061 core:RetainedEarningsAccumulatedLosses 2023-12-31 11393061 core:ShareCapital 2023-12-31 11393061 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 11393061 bus:Micro-entities 2023-01-01 2023-12-31 11393061 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 11393061 bus:FilletedAccounts 2023-01-01 2023-12-31 11393061 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 11393061 bus:RegisteredOffice 2023-01-01 2023-12-31 11393061 bus:Director1 2023-01-01 2023-12-31 11393061 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 11393061 countries:EnglandWales 2023-01-01 2023-12-31 11393061 2022-01-01 2022-12-31 11393061 2022-12-31 11393061 core:RetainedEarningsAccumulatedLosses 2022-12-31 11393061 core:ShareCapital 2022-12-31 11393061 core:Non-currentFinancialInstruments core:AfterOneYear 2022-12-31 iso4217:GBP xbrli:pure

Registration number: 11393061

Bromatech Biomed Ltd



Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2023

 

Bromatech Biomed Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3

 

Bromatech Biomed Ltd

Company Information

Director

Mr D Gatecha

Registered office

Second Floor
150-151 Fleet Street
London
EC4A 2DQ

Registered number

11393061

Accountants

Gower Accountancy Limited
Chartered Certified Accountants
Second Floor
150-151 Fleet Street
London
EC4A 2DQ

 

Bromatech Biomed Ltd

(Registration number: 11393061)
Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Current assets

 

518,286

512,179

Prepayments and accrued income

 

500

500

Total assets less current liabilities

 

518,786

512,679

Creditors: Amounts falling due after more than one year

 

(508,676)

(503,002)

Accruals and deferred income

 

(900)

(900)

Net assets

 

9,210

8,777

capital and reserves

 

Called up share capital

10,000

10,000

Profit and loss account

(790)

(1,223)

Capital and reserves

 

9,210

8,777

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the director on 18 September 2024
 

.........................................

Mr D Gatecha

Director

 

Bromatech Biomed Ltd

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Second Floor
150-151 Fleet Street
London
EC4A 2DQ
United Kingdom

These financial statements were approved by the director on 18 September 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).